The current market price of an RDT in developing countries is about U.S.$0.55–U.S.$1.50 (depending on the number of targeted species and the order quantity), compared with microscopy at U.S.$0.12–$0.40 per malaria smear. However, in the face of the rising cost of effective anti-malarial therapy, over-diagnosis can quickly decimate pharmacy budgets. Prompt and accurate diagnosis will not only improve malaria treatment, but possibly reduce morbidity due to other febrile illnesses. Therefore RDTs should be considered as tools for the composite management of febrile illnesses